SCHEMBL316095

SCHEMBL316095

[CH2]N1CCCC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1809098 0.92
SCHEMBL2539591 0.89
SCHEMBL9020643 0.78
SCHEMBL795214 0.71
SCHEMBL600282 0.69 BRD4 (0.52)
SCHEMBL6043119 0.69
SCHEMBL9020634 0.69 BRD4 (0.39)
SCHEMBL2705725 0.69
SCHEMBL5839331 0.69
Ammonia Solution, Strong SCHEMBL11513221 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 374 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024133860-A1 SYNTHESIS OF SMALL MOLECULE AGONISTS OF NEUROPTROPHIN Oculis Operations Sàrl (CH) 2024-06-27 WO claimed
WO-2023139084-A1 NEW BENZIMIDAZOLE PYRIDINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2023-07-27 WO claimed
US-20220387385-A1 NEW TREATMENT REGIMENT FOR THE TREATMENT OF NEUROLOGICAL DISEASES OR CONDITIONS ACCURE THERAPEUTICS, S.L. (ES) 2022-12-08 US claimed
CN-115052595-A Novel therapeutic methods for treating neurological diseases or disorders 阿库尔疗法公司 2022-09-13 CN claimed
EP-3993784-A1 COMBINATION THERAPY METHODS, COMPOSITIONS AND KITS Accure Therapeutics, S.L. (ES) 2022-05-11 EP claimed
EP-3458459-B1 MACROCYCLIC INDOLE DERIVATIVES BAYER AG (DE) 2022-04-27 EP claimed
CN-114206329-A Combination therapy methods, compositions and kits 阿库尔疗法公司 2022-03-18 CN claimed
WO-2021084013-A1 NEW TREATMENT REGIMEN FOR THE TREATMENT OF NEUROLOGICAL DISEASES OR CONDITIONS BIONURE FARMA, S.L. (ES) 2021-05-06 WO claimed
US-10981932-B2 Macrocyclic indole derivatives BAYER AKTIENGESELLSCHAFT (DE) 2021-04-20 US claimed
WO-2021001464-A1 COMBINATION THERAPY METHODS, COMPOSITIONS AND KITS BIONURE FARMA, S.L. (ES) 2021-01-07 WO claimed
JP-H09503491-A 1997-04-08 JP claimed
EP-0449191-B1 2-(Substituted pyrrolidinylthio)carbapenem derivatives BANYU PHARMA CO LTD (JP) 1996-07-03 EP claimed
US-5438054-A Antibacterial agent BANYU PHARMACEUTICAL CO., LTD. (JP) 1995-08-01 US claimed
WO-1995003303-A2 AZA SPIRO COMPOUNDS ACTING ON THE CHOLINERGIC SYSTEM WITH MUSCARINIC AGONIST ACTIVITY STATE OF ISRAEL, REPRESENTED BY THE PRIME MINISTER'S OFFICE, ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH (IL) 1995-02-02 WO claimed
US-5358667-A Comprising anionic cleanser, insoluble conditioner, polyhydric and quaternary ammonium compounds, suspension agent and carrier HELENE CURTIS, INC. (US) 1994-10-25 US claimed
EP-0452101-A2 Spiro bridged and unbridged heterocyclic compounds ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH (IL) 1991-10-16 EP claimed
WO-1991014687-A1 2-(SUBSTITUTED PYRROLIDINYLTHIO)CARBAPENEM DERIVATIVES BANYU PHARMACEUTICAL CO., LTD. (JP) 1991-10-03 WO claimed
EP-0449191-A1 2-(Substituted pyrrolidinylthio)carbapenem derivatives Banyu Pharmaceutical Co., Ltd. (JP) 1991-10-02 EP claimed
US-5053412-A Central nervous system disorders ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH (IL) 1991-10-01 US claimed
EP-0097340-A2 Piperazine derivatives, a process for preparing them and pharmaceutical compositions FERRER INTERNACIONAL, S.A. (ES) 1984-01-04 EP claimed